|
|
||||||||||
|
J Am Coll Cardiol, 2005; 45:1787-1793, doi:10.1016/j.jacc.2005.02.072 © 2005 by the American College of Cardiology Foundation |



* Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, New York, New York
Missouri Breaks Industries Research Inc., Timber Lake, South Dakota
College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
University of Arizona, Tucson, Arizona
|| MedStar Research Institute, Washington, DC
Manuscript received December 8, 2004; revised manuscript received February 15, 2005, accepted February 22, 2005.
* Reprint requests and correspondence: Dr. Peter M. Okin, Weill Medical College of Cornell University, 525 East 68th Street, New York, New York 10021. (Email: pokin{at}med.cornell.edu).
OBJECTIVES: This study was designed to examine whether high-sensitivity C-reactive protein (CRP) and electrocardiographic (ECG) ST-segment depression (STD) have additive utility for predicting cardiovascular disease (CVD) death and all-cause death (ACD).
BACKGROUND: C-reactive protein, a marker of systemic inflammation, and ECG STD, an index of myocardial ischemia and hypertrophy, independently predict mortality.
METHODS: Electrocardiograms and CRP levels were examined in 2,155 American Indian participants in the second Strong Heart Study examination. ST-segment depression
50 µV (n = 127) and CRP >7.0 mg/l (defining the upper quartile of CRP levels, n = 540) were considered abnormal.
RESULTS: After 5.2 ± 1.2 years follow-up there were 95 CVD deaths and 310 ACD. In univariate Cox analyses, the combination of CRP and ECG STD improved risk stratification compared to either alone, with the presence of both CRP >7.0 and ECG STD associated with a 7.7-fold increased risk of CVD death (95% confidence interval [CI] 3.3 to 18.2) and a 6.5-fold increased risk of ACD (95% CI 4.1 to 10.3). After adjustment for age, gender, and relevant risk factors, the combination of high CRP and STD remained predictive of CVD death and ACD, with the presence of both abnormal CRP and STD associated with the highest risks of CVD death (hazard ratio [HR] 3.2, 95% CI 1.1 to 10.5) and ACD (HR 3.9, 95% CI 2.1 to 7.2) and the presence of either high CRP or abnormal STD associated with intermediate risks of CVD death (HR 2.2, 95% CI 1.4 to 3.4) and ACD (HR 1.5, 95% CI 1.2 to 2.0).
CONCLUSIONS: The combination of ECG STD and CRP increases the risk of mortality, demonstrating the additive impacts of active inflammation and preclinical CVD on prognosis.
| |||||||||||
This article has been cited by other articles:
![]() |
P. M Ridker High-Sensitivity C-Reactive Protein as a Predictor of All-Cause Mortality: Implications for Research and Patient Care Clin. Chem., February 1, 2008; 54(2): 234 - 237. [Full Text] [PDF] |
||||
![]() |
S. Cicala, G. de Simone, M. J. Roman, L. G. Best, E. T. Lee, W. Wang, T. K. Welty, J. M. Galloway, B. V. Howard, and R. B. Devereux Prevalence and Prognostic Significance of Wall-Motion Abnormalities in Adults Without Clinically Recognized Cardiovascular Disease: The Strong Heart Study Circulation, July 10, 2007; 116(2): 143 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Rautaharju, C. Kooperberg, J. C. Larson, and A. LaCroix Electrocardiographic Predictors of Incident Congestive Heart Failure and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative Circulation, January 31, 2006; 113(4): 481 - 489. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |